HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) WITH CHEMOTHERAPY FOR M 1-3 MEDULLOBLASTOMA (MB) - A CHILDREN'S CANCER AND LEUKAEMIA GROUP (CCLG)/NATIONAL CANCER RESEARCH NETWORK (NCRN) STUDY

被引:0
|
作者
Taylor, Roger [1 ]
Howman, Andrew [2 ]
Brogden, Elena [2 ]
Robinson, Kathryn [3 ]
Jones, Deborah [2 ]
Gibson, Michael [2 ]
Bujkiewicz, Sylwia [3 ]
Mitra, Dipayan [4 ]
Saran, Frank [5 ]
Michalski, Antony [6 ]
Pizer, Barry [7 ]
机构
[1] Swansea Univ, Swansea, W Glam, Wales
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Univ Leicester, Leicester, Leics, England
[4] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[5] Royal Marsden Hosp, London SW3 6JJ, England
[6] Great Ormond St Hosp Sick Children, London, England
[7] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:92 / 92
页数:1
相关论文
共 11 条
  • [1] HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) WITH CHEMOTHERAPY FOR M 1-3 MEDULLOBLASTOMA (MB) - A CHILDREN'S CANCER AND LEUKAEMIA GROUP (CCLG)/NATIONAL CANCER RESEARCH NETWORK (NCRN) STUDY
    Taylor, Roger
    Howman, Andrew
    Brogden, Elena
    Robinson, Kathryn
    Jones, Deborah
    Gibson, Michael
    Bujkiewicz, Sylwia
    Mitra, Dip
    Saran, Frank
    Michalski, Antony
    Pizer, Barry
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1086 - 1086
  • [2] Children's Cancer and Leukemia Group (CCLG) Study of Hyperfractionated Accelerated Radiotherapy (HART) with Chemotherapy for M1-3 Medulloblastoma (MB)
    Taylor, R. E.
    Boota, N.
    Bujkiewicz, S.
    Lucas, J.
    Robinson, K.
    Saran, F.
    Michalski, A.
    Pizer, B. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S38 - S38
  • [3] HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) WITH CHEMOTHERAPY FOR METASTATIC MEDULLOBLASTOMA (MB): PRELIMINARY REPORT OF THE CHILDREN'S CANCER AND LEUKAEMIA GROUP (CCLG) STUDY
    Taylor, R. E.
    Boota, N.
    Bujkiewicz, S.
    Lucas, J.
    Robinson, K. J.
    Robson, K.
    Saran, F.
    Michalski, A.
    Pizer, B.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1082 - 1083
  • [4] Preliminary report of the Children's Cancer and Leukemia Group (CCLG) study of Hyperfractionated Accelerated Radiotherapy (HART) with chemotherapy for M1-3 medulloblastoma
    Taylor, Roger
    Boota, Nazia
    Bujkiewicz, Sylwia
    Lucas, Jennie
    Robinson, Kathryn
    Robson, Keith
    Saran, Frank
    Michalski, Antony
    Pizer, Barry
    NEURO-ONCOLOGY, 2008, 10 (03) : 487 - 487
  • [5] Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma - A safety/feasibility study
    Taylor, Roger E.
    Howman, Andrew J.
    Wheatley, Keith
    Brogden, Elena E.
    Large, Bridget
    Gibson, Michael J.
    Robson, Keith
    Mitra, Dipayan
    Saran, Frank
    Michalski, Antony
    Pizer, Barry L.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 (01) : 41 - 46
  • [6] Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma
    Taylor, RE
    Bailey, CC
    Robinson, KJ
    Weston, CL
    Ellison, D
    Ironside, J
    Lucraft, H
    Gilbertson, R
    Tait, DM
    Saran, F
    Walker, DA
    Pizer, BL
    Lashford, LS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (04): : 1184 - 1193
  • [7] OUTCOME FOR CHILDREN'S CANCER AND LEUKAEMIA GROUP (CCLG) PATIENTS TREATED WITH RADIOTHERAPY (RT) IN THE FIRST INTERNATIONAL CONSORTIUM LOW-GRADE GLIOMA STUDY (LGGI)
    Roger, Taylor
    Kwok-Williams, Michelle
    Bujkiewicz, Sylwia
    Robinson, Kathryn
    Walker, David
    Picton, Susan
    Weston, Claire
    Ironside, James
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 807 - 807
  • [9] Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology United Kingdom Children's Cancer Study Group PNET-3 study
    Taylor, RE
    Bailey, CC
    Robinson, K
    Weston, CL
    Ellison, D
    Ironside, J
    Lucraft, H
    Gilbertson, R
    Tait, DM
    Walker, DA
    Pizer, BL
    Imeson, J
    Lashford, LS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1581 - 1591
  • [10] Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: A Children's Cancer and Leukaemia Group (CCLG) study
    Messahel, Boo
    Williams, Richard
    Ridolfi, Antonia
    A'Hern, Roger
    Warren, William
    Tinworth, Lorna
    Hobson, Rachel
    Al-Saadi, Reem
    Whyman, Gavin
    Brundler, Marie-Anne
    Kelsey, Anna
    Sebire, Neil
    Jones, Chris
    Vujanic, Gordan
    Pritchard-Jones, Kathy
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) : 819 - 826